Real-time enrollment status for this high-risk myelodysplastic syndrome clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:43 AM UTC
| NCT Number | NCT06994676 |
| Recruiting Status | Recruiting |
| Condition | High-risk Myelodysplastic Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 72 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Crossbow Therapeutics, Inc. |
| Last Updated on CT.gov | March 16, 2026 (Mar 16, 2026) |
As of July 13, 2026: Clinical trial NCT06994676 is currently recruiting participants. This clinical trial study for high-risk myelodysplastic syndrome is actively seeking new participants at 11 locations across the United States. The study is sponsored by Crossbow Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06994676 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06994676 was last updated Mar 16, 2026 (March 16, 2026). HelloStudys verifies this status automatically.